Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization

BACKGROUND: New-onset atrial fibrillation (NOAF) is a common complication in patients with acute myocardial infarction (AMI) during hospitalization. Galectin-3 (Gal-3) is a novel inflammation marker that is significantly associated with AF. The association between post-AMI NOAF and Gal-3 during hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qianhui, Huai, Wei, Ye, Xiaoguang, Pan, Yuxia, Yang, Xinchun, Chen, Mulei, Ma, Qing-Bian, Gao, Yuanfeng, Zhang, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440583/
https://www.ncbi.nlm.nih.gov/pubmed/36057558
http://dx.doi.org/10.1186/s12872-022-02827-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440583/
https://www.ncbi.nlm.nih.gov/pubmed/36057558
http://dx.doi.org/10.1186/s12872-022-02827-y

Ejemplares similares